RMRodrigo da Rosa Mesquita

Rodrigo da Rosa Mesquita

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rodrigo da Rosa Mesquita has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Information on lifestyle habits of individuals with COVID-19 worldwide: Review of literature

    by Luiz Carlos Francelino Silva Junior, Gibson Santana, Rodrigo Mesquita, Tatiana Oliveira, Gabriel Arnozo, Aisla Santos, Etvaldo Silva Filho, Fernanda Santana, Saulo Aquino, Euclides Cunha, et al.

    Background: COVID-19 is a respiratory disease that appeared in China in late 2019 and soon spread around the world, causing a pandemic. Aims: This is study sought to systematize information about life habits in epidemiological studies in patients with COVID-19. Methods: This is a systematic review conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) recommendations. We selected articles published in PubMed, Medline and Scopus database between January 1 and April 24, 2020, using the descriptors COVID-19, SARS-CoV-2, 2019-nCoV, n-CoV and coronavirus combined with clinical profile and epidemiology. In this study, we sought to identify characteristics about patients' lifestyle habits: smoking (current or previous), alcohol consumption and physical activity. Results: We analyzed 7489 scientific studies, of which 158 had clinical and epidemiological variables, amounting 100.0563 patients. 30 studies included lifestyle habits (8,323 individuals) from five countries: Brazil, China, Korea, Spain and USA (593). A percentage of 56.5% (n = 4624) were men and 44.4% (n = 3687) women. Among the variables, smoking (current or previous) was present in 30 investigations; alcohol consumption in four and physical activity was not observed in any article. The highest smoking rates were observed in the USA (21.79%) and Spain (18.75%). Alcohol consumption was 7.73%. Being higher in Brazil (17.28%). Conclusions: New studies on the epidemiological and clinical aspects of COVID-19 include variables about lifestyle, especially smoking, alcohol consumption and physical activity. This information may offer future knowledge about the factors of illness and severity of COVID-19 in the population. Keywords: Risk factors. Coronavirus infection. Systematic review.

  • Open Access

    Extracorporeal Membrane Oxygenation in COVID-19 Treatment: a Systematic Literature Review

    by Tatiana Farias de Oliveira, Carlos Alberto de Oliveira Rocha, Aisla Graciele Galdino dos Santos, Luiz Carlos Francelino Silva Junior, Saulo Henrique Salgueiro de Aquino, Euclides José Oliveira da Cunha, Rafaela Campos Alcântara, Rodrigo da Rosa Mesquita, Gabriel Monteiro Arnozo, Etvaldo Rodrigues da Silva Filho, et al.

    The present study intends to systematically review the literature on the use of extracorporeal membrane oxygenation (ECMO) in patients with coronavirus disease 2019 (COVID-19). The research was carried out according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA). Studies were selected from PubMed/MEDLINE and LILACS databases between December 2019 and May 17 2020, using the descriptors "ECMO AND COVID-19", "Extracorporeal Membrane Oxygenation AND COVID-19", "ECLS AND COVID-19", and "Extracorporeal Life Support AND COVID-19". Exclusion criteria were government epidemiological bulletins, comments, literature reviews, and articles without full access to content. Two hundred and thirty-three scientific productions were found, however only 18 did not met the exclusion criteria and could be included in this study, amouting to a total of 911 patients - 624 (68.5%) men, 261 (28.6%) women, and 26 (2.8%) without sex information. The mean age of the patients was 53.7 years. ECMO was necessary in 274 (30.1%) people (200 [73%] submitted to venovenous ECMO, nine [3.3%] to veno-arterial ECMO, and seven [2.5%] moved between these two types or needed a more specific ECMO according to the disease prognosis). Five studies did not specify the type of ECMO used, amounting 57 (20.8%) patients. Five patients (1.8%) were discharged, 77 (28.1%) died, 125 (45.6%) remained hospitalized until publication time of their respective studies, and 67 patients (24.4%) had no outcome information. It is evident that more research, covering larger populations, must be carried out in order to clearly elucidate the role of ECMO in the treatment of COVID-19.


  • Clinical manifestations of COVID-19 in the general population: systematic review

    by Rodrigo da Rosa Mesquita, Luiz Carlos Francelino Silva Junior, Fernanda Mayara Santos Santana, Tatiana Farias de Oliveira, Rafaela Campos Alcântara, Gabriel Monteiro Arnozo, Etvaldo Rodrigues da Silva Filho, Aisla Graciele Galdino dos Santos, Euclides José Oliveira da Cunha, Saulo Henrique Salgueiro de Aquino, et al.

    Summary Clinical manifestations of COVID-19 are varied in the general population. This study aimed to systematize the literature regarding clinical manifestations of patients with confirmed COVID-19. A systematic review of the literature was conducted. A total of 8070 scientific productions were found in the databases. Among the studies, 184 met the initial inclusion criteria, with a total of 114,046 patients. After complete reading, 32 studies that did not report clinical manifestations were excluded. The 152 publications finally included a total of 41,409 individuals from at least 23 countries and 26 different clinical manifestations were reported. In percentage terms, 6 symptoms had a general prevalence greater than or equal to 25%, namely, fever (58.66%), cough (54.52%), dyspnea (30.82%), malaise (29.75%), fatigue (28.16%) and sputum/secretion (25.33%). Neurological symptoms (20.82%), dermatological manifestations (20.45%), anorexia (20.26%), myalgia (16.9%), sneezing (14.71%), sore throat (14.41%), rhinitis (14.29%), goosebumps (13.49%), headache (12.17%), chest pain (11.49%) and diarrhea (9.59%) were other common symptoms. Only one study reported dermatological manifestations. The least frequent sign/symptom was hemoptysis (1.65%). In studies with more than 100 patients, the 3 main symptoms were fever (57.93%), cough (54.21%), and dyspnea (30.64%). Dermatological manifestations do not appear among the main symptoms. The identification of all clinical manifestations of COVID-19 is essential for an early diagnosis and the adoption of preventive measures.


  • Open Access

    Information on occupation of patients with Covid-19: Literature review

    by Carlos Dornels Freire de Souza, Aisla Graciele Galdino dos Santos, Euclides José Oliveira da Cunha, Tatiana Farias de Oliveira, Saulo Henrique Salgueiro de Aquino, Rodrigo da Rosa Mesquita, Luiz Carlos Francelino Silva Junior, Fernanda Mayara Santos Santana, Rafaela Campos Alcântara, Gabriel Monteiro Arnozo, et al.

    Covid-19 was recorded for the first time in Wuhan, the capital of the Hubei province, in China, in December 2019. The disease is caused by a new coronavirus (Sars-COV-2) and transmitted by the sharing of aerosols1 . From its origin until the 21st of April of 2020, the disease had already caused the death of more than 175,000 people worldwide. There had been more than 2.5 million confirmed cases on this date2 .